Silvia Salerno

Pisa, 56126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Multifunctional auranofin analogues: dual-targeting TSPO/TrxR gold(I) complexes with activity in resistant ovarian cancer.

Multifunctional auranofin analogues: dual-targeting TSPO/TrxR gold(I) complexes with activity in resistant ovarian cancer.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: May 29, 2026

s-triazine-based Derivatives as Anticancer Agents.

s-triazine-based Derivatives as Anticancer Agents.

Journal: Mini reviews in medicinal chemistry

Published: February 06, 2026

Recent advances in the development of selective hMAO-B inhibitors for neurodegenerative diseases: An update from 2020 to present.

Recent advances in the development of selective hMAO-B inhibitors for neurodegenerative diseases: An update from 2020 to present.

Journal: European journal of medicinal chemistry

Published: January 23, 2026

Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy.

Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 11, 2025

Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases.

Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases.

Journal: Pharmacology & therapeutics

Published: May 09, 2025

2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting.

2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting.

Journal: European journal of medicinal chemistry

Published: January 31, 2025

Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity.

Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity.

Journal: ACS chemical neuroscience

Published: November 15, 2024

TSPO Radioligands for Neuroinflammation: An Overview.

TSPO Radioligands for Neuroinflammation: An Overview.

Journal: Molecules (Basel, Switzerland)

Published: July 29, 2024

Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies.

Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies.

Journal: ACS medicinal chemistry letters

Published: June 28, 2024

Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents.

Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents.

Journal: Molecules (Basel, Switzerland)

Published: March 22, 2024

Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.

Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.

Journal: Journal of medicinal chemistry

Published: December 19, 2023

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 12, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026